Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Busconi

Sports Medicine Worcester, MA Medical Doctor

NPI 1245214493 CMS profile 147003

281 Lincoln St, Department Of Orthopedic Surgery, Worcester, MA 01605

Open in the dashboard

General payments

$684,394

522 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Busconi of Worcester, MA is reported in the CMS Open Payments database as having received $684,394 across 522 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $90,342 73
2024 General $115,320 85
2023 General $121,193 56
2022 General $98,880 83
2021 General $73,979 80
2020 General $75,306 53
2019 General $109,374 92

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Busconi
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Brian Busconi were reported at $90,342. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Brian Busconi Sports Medicine median Middle half National median
2019 $109,374 $1,176 $199–$4,249 $163
2020 $75,306 $708 $96–$2,890 $114
2021 $73,979 $1,213 $152–$3,994 $132
2022 $98,880 $1,230 $159–$3,998 $149
2023 $121,193 $584 $146–$2,836 $160
2024 $115,320 $628 $163–$3,168 $164
2025 $90,342 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $240,547 125 payments
  2. Arthrex, Inc. $209,657 198 payments
  3. DePuy Synthes Products, Inc. $164,594 34 payments
  4. Linvatec Corporation $31,708 13 payments
  5. Pacira Pharmaceuticals Incorporated $18,374 9 payments
  6. Kairos Surgical Inc $7,162 20 payments
  7. Prodigy Surgical Distribution, Inc. $3,838 8 payments
  8. Flexion Therapeutics, Inc. $2,886 11 payments
  9. Biorez, Inc. $2,000 1 payment
  10. DePuy Synthes Sales Inc. $1,077 31 payments
  11. Other $2,552 72 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $303,044 63 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $185,652 29 payments
  3. Royalty or License $144,743 24 payments
  4. Travel and Lodging $26,223 73 payments
  5. Food and Beverage $11,226 324 payments
  6. Education $10,206 8 payments
  7. Compensation for serving as faculty or as a speaker for a medical education program $3,300 1 payment
Products named General payments · program years 2019–2025
  1. Omnispan Orthocord $200,991 43 payments
  2. RIGIDLOOP Sports Surgical $200,991 43 payments
  3. MILAGRO Sports Surgical $197,386 41 payments
  4. MITEK CRUCIATE+ $102,090 16 payments
  5. RIGIDLOOP Sports Surgical $53,773 16 payments
  6. OMNISPAN $47,078 14 payments
  7. CRUCIATE $42,653 8 payments
  8. BIOBRACE 23MM $31,691 12 payments
  9. HEALIX $28,325 7 payments
  10. MILAGRO Sports Surgical $26,432 16 payments
  11. Other $76,092 191 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$7,885

Medicare's payments for the services billed

Medicare patients

37

Average age 63

Services billed

392

16 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 68%
High blood pressure 43%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $41
$41 — —
Zilretta
  • Pacira Pharmaceuticals Incorporated $5
$5 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

522 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record